Home/Filings/4/0001209191-18-008508
4//SEC Filing

MCGRATH JOHN 4

Accession 0001209191-18-008508

CIK 0001604464other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 5:43 PM ET

Size

11.1 KB

Accession

0001209191-18-008508

Insider Transaction Report

Form 4
Period: 2018-02-06
MCGRATH JOHN
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2018-02-06+25,000114,654 total
  • Award

    Employee Stock Option (Right to Buy)

    2018-02-06+50,00050,000 total
    Exercise: $35.80Exp: 2025-02-06Common Stock (50,000 underlying)
  • Tax Payment

    Common Stock

    2018-02-06$35.80/sh4,279$153,188110,375 total
Footnotes (3)
  • [F1]These restricted stock units vest in four equal annual installments on each of the first, second, third and fourth anniversaries of the grant date, subject to the reporting person's continuous service.
  • [F2]Shares withheld to cover tax obligation from settlement of vested restricted stock units.
  • [F3]1/48th of the shares subject to the stock option vest and become exercisable each month following February 6, 2018.

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1
  • filerCIK 0001205442

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:43 PM ET
Size
11.1 KB